[1,1'-Bi(cyclohexylidene)]-2-one

Catalog No.: 
ACOVVS192
CAS No.: 
1011-12-7
Molecular Formula: 
C12H18O
Molecular Weight: 
178.27
[1,1'-Bi(cyclohexylidene)]-2-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$233.00InquiryInquiry
250mg95%$435.00InquiryInquiry
1g95%$1088.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name[1,1'-Bi(cyclohexylidene)]-2-one
IUPAC Name[1,1'-bi(cyclohexylidene)]-2-one
MDL No.MFCD19443386
Molecular FormulaC12H18O
Molecular Weight178.27
SMILESO=C(CCCC1)C1=C2CCCCC2
InChI KeyTYDSIOSLHQWFOU-UHFFFAOYSA-N
Synonym2-cyclohexylidenecyclohexanone;BICYCLOHEXYLIDENE-2-ONE;2-Cyclohexylidencyclohexanon;2-cyclohexylidenecyclohexan-1-one;2-(Cyclohexane-1-ylidene)cyclohexane-1-one;Bicyclohexyliden-2-one;Cyclohexanone, 2-cyclohexylidene-;Nsc61652
CAS No.1011-12-7

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACOVVS192 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACOVVS192 route product structure diagram
    ACOVVS1921011-12-7
Inquiry

2. ACOVVS192 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACOVVS192 route product structure diagram
    ACOVVS1921011-12-7
Inquiry

3. ACOVVS192 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACOVVS192 route product structure diagram
    ACOVVS1921011-12-7
Inquiry

Comments (0)